Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:SNPX) from Buy to Hold.
Maxim Group Downgrades Synaptogenix to Hold
Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:SNPX) from Buy to Hold.
Related Posts
Analysts Cheer Texas Instruments’ Q4 Amid China & Macro Headwinds; Also Caution Against Auto Slowdown, Margin Headwinds
Benchmark analyst Cody Acree maintained Texas Instruments Inc (NASDAQ:TXN) with a Buy and raised the price target from $189 to $203. The…
5 Analysts Have This to Say About LendingTree
Within the last quarter, LendingTree (NASDAQ:TREE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Leslie’s Reaffirms FY23 Guidance
The Company reaffirms its outlook for the full year of Fiscal 2023:
Sales
$1,560 to $1,640 million
Gross profit
$667 to $708 million
Net income
$131 to $146 million
Adjusted